News

Supernus Pharmaceuticals' Upcoming Engagements and Insights

Supernus Pharmaceuticals' Upcoming Engagements and Insights

Supernus Pharmaceuticals Engages with Investors

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company dedicated to developing treatments for central nervous system (CNS) diseases, has made exciting advancements in its journey. The company has announced its involvement in several investor conferences scheduled for September, affording investors the chance to gain insight into its operational objectives and product developments.

Upcoming Investor Conferences

Supernus Pharmaceuticals will partake in a series of key investor conferences. These events will provide an excellent platform for management to share insights and engage with investors.

Cantor Global Healthcare Conference

This prominent conference will take place on Wednesday, September 3, 2025, at 8:00 a.m. ET. Supernus management will be available to discuss the company’s strategic initiatives and growth prospects. The event will be held at the New York Marriott Marquis in New York City.

Wells Fargo Healthcare Conference

Following closely, the Wells Fargo Healthcare Conference is set for Thursday, September 4, 2025, at 8:45 a.m. ET. Held at Encore Boston Harbor in Everett, Massachusetts, this conference will also serve as a valuable opportunity for Supernus to engage with its stakeholders.

TD Cowen's 5th Annual Summit

On Thursday, September 18, 2025, Supernus will participate in the virtual TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit. The management will be involved in a fireside chat at 10:40 a.m. ET, discussing innovative approaches and future directions in treating CNS disorders.

Engaging with Investors

Investors interested in meeting with Supernus Pharmaceuticals' management during these conferences are encouraged to reach out to the respective conference coordinators. This is a pivotal moment for the company, as it seeks to strengthen relationships and provide transparency regarding its business strategies.

Accessing Live Presentations

For those unable to attend in person, Supernus Pharmaceuticals will offer live audio webcasts of these presentations. Interested parties can access the webcasts in the Events & Presentations section of the Supernus Pharmaceuticals website. The webcasts will be archived for 60 days, allowing wider access after the events conclude.

About Supernus Pharmaceuticals

Supernus Pharmaceuticals is at the forefront of developing new therapies for CNS diseases. With a diverse portfolio, the company has developed treatments for various conditions including attention-deficit hyperactivity disorder (ADHD), Parkinson’s disease (PD), epilepsy, migraine, and more. Their dedication to advancing innovative CNS treatments underscores their commitment to improving patient outcomes.

The portfolio also includes promising drug candidates aimed at treating conditions such as depression and epilepsy, reflecting the company’s mission to address significant unmet medical needs in the CNS arena.

Contact Information

For further inquiries or to arrange a meeting, please contact:

Jack A. Khattar, President and CEO
Timothy C. Dec, Senior Vice President and CFO
Supernus Pharmaceuticals, Inc.
(301) 838-2591

Investor Contact:
Peter Vozzo
ICR Healthcare
(443) 213-0505
peter.vozzo@icrhealthcare.com

Frequently Asked Questions

What is Supernus Pharmaceuticals known for?

Supernus Pharmaceuticals specializes in developing products for the treatment of central nervous system (CNS) diseases, including ADHD and epilepsy.

When are the upcoming investor conferences?

Supernus will participate in investor conferences on September 3, 4, and 18, 2025.

How can investors access the live webcasts?

Investors can access live audio webcasts through the Events & Presentations section on the Supernus Pharmaceuticals website.

Who should I contact for more information about meetings?

Interested parties should contact the conference coordinators for the respective events to arrange meetings.

What types of conditions does Supernus focus on?

Supernus focuses on treating CNS disorders, including ADHD, dyskinesia in Parkinson's disease, and epilepsy, among others.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Milton Hershey School's New Project: Founders Grove Launches

Updated Category News Views 246

Breaking New Ground with Founders Grove It’s not every day a community gets a new lease on life through bricks and mortar, but Milton Hershey School (MHS) just did exactly that. They've broken ground on Founders Grove, a piece of the Hershey West End development puzzle that reflects both history and future potential. This isn’t just another housing project—this...

Continue Reading
212NYC Gala Celebrates Ad Industry's Human Touch

Updated Category News Views 197

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Continue Reading
Tenax Therapeutics Faces Securities Fraud Class Action

Updated Category News Views 132

Where Did It All Go Wrong for Tenax? They say the stock market is a rollercoaster, but Tenax Therapeutics, Inc. (NASDAQ: TENX) seems to have taken that expression way too literally. Imagine watching your investments tumble by nearly 90% in a single day. On August 10, 2026, that was the grim reality for Tenax's stockholders when the company's shares plummeted from over $13...

Continue Reading
Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 58

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
McKinley Irvin Earns Top 2027 Rankings in Family Law

Updated Category News Views 103

A Legal Eagle Soars High in 2027 Oh, the legal world can be as cutthroat as the stock market some days, especially when you're gunning for those top-tier rankings. This year, McKinley Irvin has managed to ruffle a few feathers in the Pacific Northwest, claiming top honors in the 2027 Best Law Firms rankings. And let me tell you, this wasn’t just handed to them on a...

Continue Reading
Tiana Marbuery Joins ALTA Division at Partner

Updated Category News Views 174

Tiana Marbuery Dives In at Partner Forget flashy office parties and buzzword bingo. Today’s gig's all about substance. Partner Engineering and Science, Inc. just snagged themselves a heavy-hitter with Tiana Marbuery joining the ranks as Technical Director in their ALTA Division. This ain't a small fry deal—Marbuery's packing over eight years of hard-earned chops in...

Continue Reading
Blue Friday Sales: A Princess Cruises' Steal

Updated Category News Views 223

Setting Sail on Savings: Princess Cruises' Offerings When folks start talking about Black Friday, you probably think of TVs or gadgets, but Princess Cruises is flipping that idea with their 'Blue Friday' sale, running from November 6 through December 7, 2026. Now, cruises aren't your traditional doorbuster, but a vacation might just be the kind of experience worth...

Continue Reading
Gigli's New Beverages Aim to Refresh Wellness Market

Updated Category News Views 46

Raising the Bar on Everyday Sips Gigli just shook up Miami – and possibly the whole wellness drinks scene – with the rollout of its Daily Functional Line and SKINNY Mocktails. If you've ever found yourself wishing your drink did more than just wet your whistle, these stacks of goodness might be music to your ears. They're not just about filling a cup; they're...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 99

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Recent Disclosures by Learning Technologies Group

Updated Category News Views 41

Insights into Learning Technologies Group Plc Disclosures In the world of corporate finance, transparency is vital. This is especially true for companies listed on stock exchanges, where shareholders need to be informed about significant changes in positions held by major stakeholders. Recently, Learning Technologies Group Plc has made relevant disclosures that comply...

Continue Reading
Projected Growth in Animal Antibacterial Market to USD 6.5B

Updated Category News Views 58

The Animal Antibacterial and Antibiotics Market Overview The Animal Antibacterial and Antibiotics Market is undergoing remarkable growth, primarily fueled by a variety of key factors including the surging production of livestock and intensive farming practices. These elements drive the need for effective antibacterial and antibiotic solutions to safeguard animal health. A...

Continue Reading
EQT Corp: Positive Growth Forecast with Recent Upgrades

Updated Category News Views 75

Positive Outlook for EQT Corp Recently, Citi has upgraded EQT Corp. (NYSE:EQT) from a Neutral to a Buy rating, adjusting the price target significantly from $37 to $44. This improvement is largely driven by expectations of a tightening U.S. gas market by 2025, showcasing confidence in the company’s position as the largest natural gas producer in the United States....

Continue Reading
Market Anticipation Rises as Key Updates Loom Ahead

Updated Category News Views 197

Global Market Sentiment Builds Amid Developments As we take a look at the upcoming day in European and global markets, a significant test lies ahead for France's government. Prime Minister Francois Bayrou is anticipated to unveil a plan in a crucial speech aimed at modifying pension reforms in exchange for support from the left as a means to ensure budget approval. The...

Continue Reading